VitaSpring Biomedical Co. Ltd. (VSBC)
OTCMKTS · Delayed Price · Currency is USD
0.0318
0.00 (0.00%)
At close: Oct 8, 2026
VitaSpring Biomedical Market Cap
VitaSpring Biomedical has a market cap or net worth of $6.58 million as of October 9, 2026. It is the 43,832nd most valuable company in the world and the 5,901st biggest in the United States. Its market cap has decreased by 78.80% in one year.
Market Cap
6.58M
Enterprise Value
8.98M
Revenue
n/a
Global Rank
Country Rank
#5,901 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since November 13, 2019, VitaSpring Biomedical's market cap has decreased from 22.89M to 6.58M, a decrease of -71.24%. That is a compound annual growth rate of -18.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 2.30M | -99.92% |
| Dec 29, 2022 | 2.97B | -26.15% |
| Dec 27, 2021 | 4.03B | 17,490.12% |
| Nov 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aditxt | 3.19M |
| Vaccinex | 3.08M |
| Pacific Software | 3.06M |
| Bioxytran | 2.74M |
| GPL Holdings | 2.56M |
| Enzolytics | 2.42M |
| Abpro Holdings | 2.36M |
| International Stem Cell | 2.29M |